acitretin has been researched along with Abnormalities, Drug-Induced in 24 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (12.50) | 18.7374 |
| 1990's | 13 (54.17) | 18.2507 |
| 2000's | 3 (12.50) | 29.6817 |
| 2010's | 3 (12.50) | 24.3611 |
| 2020's | 2 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Haug, U; Kollhorst, B; Reinold, J; Temme, HL; Wentzell, N | 1 |
| Andersen, JT; Clausen, SS; Noergaard, M | 1 |
| Bourrat, E; Mahé, E; Petit, A | 1 |
| Belinchón, I; Carrascosa, JM; Carretero, G; Dehesa, L; Ferrandiz, C; González-Quesada, A; Jorquera, E; Moreno, JC; Muñoz, C; Notario, J; Peral, F; Puig, L; Ribera, M; Vanaclocha, F; Vidal, D | 1 |
| Alla, F; Mezzarobba, M; Raguideau, F; Ricordeau, P; Weill, A; Zureik, M | 1 |
| Geiger, JM; Walker, M | 1 |
| Baudin, M; Geiger, JM; Saurat, JH | 1 |
| Abbott, M; Chan, A; Hanna, M; Keane, RJ | 1 |
| de Die-Smulders, CE; Sastrowijoto, P; Sturkenboom, MC; van der Linden, E; van Katwijk, C; Veraart, J | 1 |
| Monga, M | 1 |
| Guillonneau, M; Jacqz-Aigrain, E | 1 |
| Geiger, JM; Maradit, H | 1 |
| Katz, HI; Leach, EE; Waalen, J | 1 |
| Bouvy, ML; Cornel, MC; De Jong-Van den Berg, LT; Stricker, BH; Sturkenboom, MC; Wesseling, H | 1 |
| Bochert, G; Chahoud, I; Löfberg, B; Nau, H | 1 |
| Halioua, B; Saurat, JH | 1 |
| Löfberg, B; Nau, H; Reiners, J; Spielmann, H | 1 |
| Nau, H | 1 |
| Hummler, H; Kistler, A | 1 |
| Kochhar, DM; Kraft, JC; Löfberg, B; Nau, H; Reiners, J | 1 |
| Gollnick, H; Orfanos, CE | 1 |
8 review(s) available for acitretin and Abnormalities, Drug-Induced
| Article | Year |
|---|---|
Teratogenic risk with etretinate and acitretin treatment.
Topics: Abnormalities, Drug-Induced; Acitretin; Adolescent; Adult; Animals; Contraceptives, Oral; Dose-Response Relationship, Drug; Etretinate; Female; Fetal Diseases; Humans; Infant, Newborn; Maternal-Fetal Exchange; Pregnancy; Pregnancy Outcome; Prenatal Exposure Delayed Effects; Reproducibility of Results; Risk Factors | 1994 |
Oral retinoids and pregnancy.
Topics: Abnormalities, Drug-Induced; Acitretin; Administration, Oral; Etretinate; Female; Humans; Isotretinoin; Keratolytic Agents; Pregnancy | 1996 |
Vitamin A and its congeners.
Topics: Abnormalities, Drug-Induced; Acitretin; Etretinate; Female; Humans; Isotretinoin; Pregnancy; Retinoids; Tretinoin; Vitamin A | 1997 |
[Teratogenic effects of vitamin A and its derivates].
Topics: Abnormalities, Drug-Induced; Acitretin; Animals; Female; Humans; Isotretinoin; Keratolytic Agents; Pregnancy; Retinoids; Teratogens; Vitamin A | 1997 |
Potential risk of birth defects after acitretin discontinuation.
Topics: Abnormalities, Drug-Induced; Acitretin; Female; Humans; Keratolytic Agents; Pregnancy; Pregnancy Outcome; Risk Factors | 1999 |
Acitretin in psoriasis: an overview of adverse effects.
Topics: Abnormalities, Drug-Induced; Acitretin; Drug Interactions; Etretinate; Eye Diseases; Female; Humans; Hyperlipidemias; Hyperostosis; Keratolytic Agents; Liver; Male; Mucous Membrane; Pancreatitis; Pseudotumor Cerebri; Skin Diseases | 1999 |
Acitretin (Neotigason). A review of pharmacokinetics and teratogenicity and hypothesis on metabolic pathways.
Topics: Abnormalities, Drug-Induced; Acitretin; Animals; Biotransformation; Etretinate; Humans; Tretinoin | 1992 |
Risk: benefit ratio in the treatment of psoriasis with systemic retinoids.
Topics: Abnormalities, Drug-Induced; Acitretin; Adult; Aged; Bone Diseases; Chemical and Drug Induced Liver Injury; Etretinate; Eye Diseases; Female; Humans; Lipids; Male; Middle Aged; Psoriasis; Risk Factors; Skin Diseases; Tretinoin | 1990 |
1 trial(s) available for acitretin and Abnormalities, Drug-Induced
| Article | Year |
|---|---|
[Etretinate: pro and con. Risk-benefit analysis of systemic retinoid therapy in psoriasis and recent developments: free aromatic acid, arotinoids].
Topics: Abnormalities, Drug-Induced; Acitretin; Benzoates; Chemical and Drug Induced Liver Injury; Clinical Trials as Topic; Etretinate; Humans; Lipids; Long-Term Care; Prognosis; Psoriasis; Retinoids; Risk; Skin; Tretinoin | 1985 |
15 other study(ies) available for acitretin and Abnormalities, Drug-Induced
| Article | Year |
|---|---|
Use of Acitretin Among Girls and Women of Childbearing Age and Occurrence of Acitretin-Exposed Pregnancies in Germany.
Topics: Abnormalities, Drug-Induced; Acitretin; Child; Female; Germany; Humans; Pregnancy | 2023 |
Paternal acitretin exposure and the risk of miscarriage and major congenital malformations: A nationwide register-based cohort study.
Topics: Abnormalities, Drug-Induced; Abortion, Spontaneous; Acitretin; Adult; Denmark; Drug Prescriptions; Female; Humans; Infant, Newborn; Male; Maternal Age; Paternal Age; Paternal Exposure; Pregnancy; Registries; Risk Factors; Young Adult | 2020 |
[Reflections on the new rules for dispensing acitretin (Soriatane)].
Topics: Abnormalities, Drug-Induced; Acitretin; Decision Making; Female; Humans; Keratolytic Agents; Paternalism; Personal Autonomy; Physician-Patient Relations; Pregnancy | 2013 |
Guidelines for the use of acitretin in psoriasis. Psoriasis Group of the Spanish Academy of Dermatology and Venereology.
Topics: Abnormalities, Drug-Induced; Acitretin; Biotransformation; Cardiovascular Diseases; Comorbidity; Contraindications; Drug Administration Schedule; Drug Interactions; Female; Gene Expression Regulation; Humans; Immunosuppressive Agents; Keratinocytes; Metabolic Syndrome; Pregnancy; Pregnancy Complications; Psoriasis; Receptors, Retinoic Acid; Risk Assessment; Tetracyclines | 2013 |
Compliance with pregnancy prevention plan recommendations in 8672 French women of childbearing potential exposed to acitretin.
Topics: Abnormalities, Drug-Induced; Acitretin; Adolescent; Adult; Contraception Behavior; Family Planning Services; Female; France; Guideline Adherence; Humans; Keratolytic Agents; Middle Aged; Young Adult | 2015 |
Is there a reproductive safety risk in male patients treated with acitretin (neotigason/soriatane?
Topics: Abnormalities, Drug-Induced; Abortion, Spontaneous; Acitretin; Animals; Female; Humans; Keratolytic Agents; Male; Paternal Exposure; Pregnancy | 2002 |
[Patient memo. Advice for patients with psoriasis and using Soriatane].
Topics: Abnormalities, Drug-Induced; Acitretin; Adult; Cholesterol; Dose-Response Relationship, Drug; Female; Humans; Keratolytic Agents; Liver; Male; Monitoring, Physiologic; Pregnancy; Psoriasis; Triglycerides | 2004 |
Topical retinoids during pregnancy (continued).
Topics: Abnormalities, Drug-Induced; Acitretin; Administration, Topical; Craniofacial Abnormalities; Female; France; Humans; Infant, Newborn; Maternal Exposure; Naphthalenes; Pregnancy; Prenatal Exposure Delayed Effects; Retinoids; Tretinoin | 2005 |
Severe limb defects and craniofacial anomalies in a fetus conceived during acitretin therapy.
Topics: Abnormalities, Drug-Induced; Acitretin; Adult; Arm; Craniofacial Abnormalities; Female; Humans; Infant, Newborn; Keratoderma, Palmoplantar; Keratolytic Agents; Leg; Limb Deformities, Congenital; Male; Pregnancy; Pregnancy Complications; Pregnancy Trimester, First; Radiography | 1995 |
Two new retinoids for psoriasis.
Topics: Abnormalities, Drug-Induced; Acitretin; Alopecia; Cheilitis; Clinical Trials as Topic; Dermatologic Agents; Drug Costs; Drug Interactions; Feces; Gels; Humans; Keratolytic Agents; Nicotinic Acids; Psoriasis | 1997 |
Teratogenicity of the 13-cis and all-trans-isomers of the aromatic retinoid etretin: correlation to transplacental pharmacokinetics in mice during organogenesis after a single oral dose.
Topics: Abnormalities, Drug-Induced; Acitretin; Animals; Bone and Bones; Dermatologic Agents; Female; Keratolytic Agents; Maternal-Fetal Exchange; Mice; Mice, Inbred Strains; Pregnancy; Stereoisomerism; Structure-Activity Relationship; Tretinoin | 1990 |
Teratogenicity of steady-state concentrations of etretinate and metabolite acitretin maintained in maternal plasma and embryo by intragastric infusion during organogenesis in the mouse: a possible model for the extended elimination phase in human therapy.
Topics: Abnormalities, Drug-Induced; Acitretin; Animals; Embryonic and Fetal Development; Etretinate; Female; Infusion Pumps, Implantable; Maternal-Fetal Exchange; Mice; Models, Biological; Pregnancy; Tretinoin | 1990 |
Correlation of transplacental and maternal pharmacokinetics of retinoids during organogenesis with teratogenicity.
Topics: Abnormalities, Drug-Induced; Acitretin; Animals; Biotransformation; Carbon Radioisotopes; Embryonic and Fetal Development; Female; Maternal-Fetal Exchange; Mice; Mice, Inbred Strains; Placenta; Pregnancy; Radioisotope Dilution Technique; Retinoids; Teratogens; Tretinoin | 1990 |
Teratogenesis and reproductive safety evaluation of the retinoid etretin (Ro 10-1670).
Topics: Abnormalities, Drug-Induced; Acitretin; Administration, Oral; Animals; Dose-Response Relationship, Drug; Embryo, Mammalian; Female; Fetal Death; Mice; Pregnancy; Pregnancy, Animal; Rabbits; Rats; Reproduction; Teratogens; Tretinoin | 1985 |
Transplacental pharmacokinetics of teratogenic doses of etretinate and other aromatic retinoids in mice.
Topics: Abnormalities, Drug-Induced; Acitretin; Animals; Cells, Cultured; Chromatography, High Pressure Liquid; Etretinate; Female; Maternal-Fetal Exchange; Mice; Mice, Inbred Strains; Molecular Structure; Placenta; Pregnancy; Tretinoin | 1988 |